Omega-3 (EPA+DHA)
DHA-forward fish or algal oil
The largest meta-analysis on the topic — 51 trials — found omega-3 lowers resting heart rate by about 2 beats per minute, an effect driven by DHA rather than EPA. Fish-oil trials also increase vagally-mediated heart-rate variability. This is one of the few supplement effects large and steady enough to see in a wearable's resting-heart-rate trend over two to three months.
Strong: 51 RCTs with ~3,000 participants, a clear dose–response for blood pressure across 71 RCTs, and mechanistic coherence (membrane effects on sinus-node cells). Effect sizes are modest but highly consistent.
DHA incorporates into cardiac cell membranes, slowing pacemaker cells and shifting autonomic balance toward the parasympathetic side.
Anyone with a low omega-3 index; DHA-forward oils for heart-rate effects; 4–12 weeks to see it. Keep to ≤3 g/day — higher prescription doses carry an atrial-fibrillation signal.
Every estimate, against a line of no effect
Diamonds are point estimates; the hairline is the 95% confidence interval where the trial reported one.
- Resting heart ratebpm · Hidayat 2018−2.23−3.07 … −1.40
- Resting heart rate (DHA-only trials)bpm · Hidayat 2018−2.47[not reported]
- Systolic blood pressure (2–3 g/day)mmHg · Zhang 2022−2.00[not reported]
- Systolic BP in hypertensivesmmHg · Zhang 2022−4.50[not reported]
Units are never mixed on one line: each scale gets its own axis. Where a trial reported no confidence interval we leave it blank rather than inventing one.
We compare each effect to the typical night-to-night noise of that metric. Effects smaller than the noise are real but invisible in a week of data.
- Resting heart rateLikely visibleeffect: 2.23 bpmnightly noise: ±2 bpm
- Resting heart rate (DHA-only trials)Likely visibleeffect: 2.47 bpmnightly noise: ±2 bpm
3 studies across 9 years
- · Mild bleeding-time increase — caution with anticoagulants; stop 2 weeks pre-surgery.
- · Atrial fibrillation signal at ≥4 g/day — stay ≤3 g.
References
- 1.Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trialsEuropean Journal of Clinical Nutrition · 2018 · meta-analysis · 51 trials · n = 3,000
Heart rate −2.23 bpm (95% CI −3.07 to −1.40); DHA −2.47 bpm; EPA alone no effect.
- 2.Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trialsAmerican Journal of Clinical Nutrition · 2013 · meta-analysis · 15 trials
Increased high-frequency (vagal) HRV with fish oil.
- 3.Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trialsJournal of the American Heart Association · 2022 · meta-analysis · 71 trials · n = 4,973
Optimal BP reduction at 2–3 g/day EPA+DHA; larger in hypertensive participants.
Umbral is a wellness product, not a medical device. It does not diagnose, treat, cure or prevent any disease. Supplement information is educational; talk to a clinician before starting anything, especially if you are pregnant, under 18, managing a condition or taking medication.